Multiomics and eXplainable artificial intelligence for decision support in insulin resistance early diagnosis: A pediatric population-based longitudinal study

dc.contributor.authorTorres-Martos, Álvaro
dc.contributor.authorAnguita Ruiz, Augusto
dc.contributor.authorBustos-Aibar, Mireia
dc.contributor.authorRamírez-Mena, Alberto
dc.contributor.authorArteaga, María
dc.contributor.authorBueno, Gloria
dc.contributor.authorLeis Trabazo, María Rosaura
dc.contributor.authorAguilera, Concepción M.
dc.contributor.authorAlcalá, Rafael
dc.contributor.authorAlcalá-Fernández, Jesús
dc.date.accessioned2026-01-20T10:32:07Z
dc.date.available2026-01-20T10:32:07Z
dc.date.issued2024-08-20
dc.description.abstractPediatric obesity can drastically heighten the risk of cardiometabolic alterations later in life, with insulin resistance standing as the cornerstone linking adiposity to the increased cardiovascular risk. Puberty has been pointed out as a critical stage after which obesity-associated insulin resistance is more difficult to revert. Timely prediction of insulin resistance in pediatric obesity is therefore vital for mitigating the risk of its associated comorbidities. The construction of effective and robust predictive systems for a complex health outcome like insulin resistance during the early stages of life demands the adoption of longitudinal designs for more causal inferences, and the integration of factors of varying nature involved in its onset. In this work, we propose an eXplainable Artificial Intelligence-based decision support pipeline for early diagnosis of insulin resistance in a longitudinal cohort of 90 children. For that, we leverage multi-omics (genomics and epigenomics) and clinical data from the pre-pubertal stage. Different data layers combinations, pre-processing techniques (missing values, feature selection, class imbalance, etc.), algorithms, training procedures were considered following good practices for Machine Learning. SHapley Additive exPlanations were provided for specialists to understand both the decision-making mechanisms of the system and the impact of the features on each automatic decision, an essential issue in high-risk areas such as this one where system decisions may affect people’s lives. The system showed a relevant predictive ability (AUC and G-mean of 0.92). A deep exploration, both at the global and the local level, revealed promising biomarkers of insulin resistance in our population, highlighting classical markers, such as Body Mass Index z-score or leptin/adiponectin ratio, and novel ones such as methylation patterns of relevant genes, such as HDAC4, PTPRN2, MATN2, RASGRF1 and EBF1. Our findings highlight the importance of integrating multi-omics data and following eXplainable Artificial Intelligence trends when building decision support systems.
dc.description.peerreviewedSI
dc.description.sponsorshipThe Instituto de Salud Carlos III cofunded by the European Union and ERDF A way of making Europe (grant numbers PI20/00711, PI20/00563, PI20/00924, P20/00988, PI23/00028, PI23/00129, PI23/01032, PI23/00165 and also PI23/00191),
dc.description.sponsorshipThe European Union through the Horizon Europe Framework Programme (eprObes project, grant number GA 101080219).
dc.description.sponsorshipInstituto de Salud Carlos III for personal funding of A.A.R, A.T.M and M.B.A.: i-PFIS and PFIS contracts: IIS doctorates - company in health sciences and technologies of the Strategic Health Action (IFI17/00048, IFI22/00013 and FI23/00042).
dc.description.sponsorshipThe support from the grant FJC2021- 046952-I by Ministerio de Ciencia, Innovación y Universidades y Agencia Estatal de Investigación. Funding for open access charge: Universidad de Granada/CBUA
dc.identifier.citationTorres-Martos, Á., Anguita-Ruiz, A., Bustos-Aibar, M., Ramírez-Mena, A., Arteaga, M., Bueno, G., Leis, R., Aguilera, C. M., Alcalá, R., & Alcalá-Fdez, J. (2024). Multiomics and eXplainable artificial intelligence for decision support in insulin resistance early diagnosis: A pediatric population-based longitudinal study. Artificial intelligence in medicine, 156, 102962. https://doi.org/10.1016/j.artmed.2024.102962
dc.identifier.doi10.1016/j.artmed.2024.102962
dc.identifier.issn0933-3657
dc.identifier.urihttps://hdl.handle.net/10347/45281
dc.journal.titleArtificial Intelligence In Medicine
dc.language.isoeng
dc.page.final14
dc.page.initial1
dc.publisherElsevier
dc.relation.projectIDinfo:eu-repo/grantAgreement/ISCIII/Plan Estatal de Investigación Científica y Técnica y de Innovación 2017-2020 (ISCIII)/PI20%2F00711/ES/
dc.relation.projectIDinfo:eu-repo/grantAgreement/ISCIII/Plan Estatal de Investigación Científica y Técnica y de Innovación 2017-2020 (ISCIII)/PI20%2F00563/ES/
dc.relation.projectIDinfo:eu-repo/grantAgreement/ISCIII/Plan Estatal de Investigación Científica y Técnica y de Innovación 2017-2020 (ISCIII)/PI20%2F00924/ES/
dc.relation.projectIDinfo:eu-repo/grantAgreement/ISCIII/Plan Estatal de Investigación Científica y Técnica y de Innovación 2017-2020 (ISCIII)/PI20%2F00988/ES/
dc.relation.projectIDinfo:eu-repo/grantAgreement/ISCIII/Plan Estatal de Investigación Científica, Técnica y de Innovación para el periodo 2021-2023/PI23%2F00028/ES/
dc.relation.projectIDinfo:eu-repo/grantAgreement/ISCIII/Plan Estatal de Investigación Científica, Técnica y de Innovación para el periodo 2021-2023/PI23%2F00129/ES/
dc.relation.projectIDinfo:eu-repo/grantAgreement/ISCIII/Plan Estatal de Investigación Científica, Técnica y de Innovación para el periodo 2021-2023/PI23%2F01032/ES/
dc.relation.projectIDinfo:eu-repo/grantAgreement/ISCIII/Plan Estatal de Investigación Científica, Técnica y de Innovación para el periodo 2021-2023/PI23%2F00165/ES/
dc.relation.projectIDinfo:eu-repo/grantAgreement/ISCIII/Plan Estatal de Investigación Científica, Técnica y de Innovación para el periodo 2021-2023/PI23%2F00191/ES/
dc.relation.projectIDinfo:eu-repo/grantAgreement/EC/HE/101080219/EU/
dc.relation.publisherversionhttps://doi.org/10.1016/j.artmed.2024.102962
dc.rights© 2024 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license. Attribution-NonCommercial-NoDerivatives 4.0 International
dc.rights.accessRightsopen access
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/
dc.subjectPediatric obesity
dc.subjectInsulin resistance
dc.subjectEpigenomics
dc.subjectMultiomics
dc.subjectMachine Learning
dc.subjectExplainable Artificial Intelligence
dc.subject.classification32 Ciencias médicas
dc.titleMultiomics and eXplainable artificial intelligence for decision support in insulin resistance early diagnosis: A pediatric population-based longitudinal study
dc.typejournal article
dc.type.hasVersionVoR
dc.volume.number156
dspace.entity.typePublication
relation.isAuthorOfPublication1e3d57c2-ad35-4203-8ea0-f72f75021208
relation.isAuthorOfPublication.latestForDiscovery1e3d57c2-ad35-4203-8ea0-f72f75021208

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
2024_aim_leis_multiomics.pdf
Size:
1.65 MB
Format:
Adobe Portable Document Format